-
Founded in:
2011-03-08 -
Country:
China -
Address:
Yuanmei Village, Shitan Town, Zengcheng District, Guangzhou (Pomegranate Base) -
Tax NO.:
91440183569775273G -
Registered Funds:
112 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium chloride |
Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure.
More
Sodium chloride is an electrolyte supplement. Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining normal blood and extracellular fluid volume and osmotic pressure. The normal serum sodium concentration is 135-145mmol/L, accounting for 92% of plasma cations and 90% of total osmotic pressure, so the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum chloride concentration is 98-106mmol/L. Sodium and chloride ions in the human body are mainly regulated by the hypothalamus, posterior pituitary and kidneys to maintain the stability of body fluid volume and osmotic pressure. |
7647-14-5 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| GLUCOSE |
Caloric supplementation, treatment of hypoglycemia, used with insulin to treat hyperkalemia, rapid intravenous push of hypertonic glucose injection to dehydrate tissues, maintain and regulate the osmotic pressure of peritoneal dialysis fluid
More
Caloric supplementation, treatment of hypoglycemia, used with insulin to treat hyperkalemia, rapid intravenous push of hypertonic glucose injection to dehydrate tissues, maintain and regulate the osmotic pressure of peritoneal dialysis fluid |
58367-01-4 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydroxyethyl starch |
After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation.
More
After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation. |
9005-27-0 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydroxyethyl starch |
After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation.
More
After intravenous infusion, this product stays in the blood for a long time, increasing plasma osmotic pressure, increasing tissue fluid reflux, rapidly increasing blood volume, diluting blood, and increasing the negative charge of cell membranes, causing aggregated cells to disaggregate, reducing systemic blood viscosity, and improving microcirculation. |
9005-27-0 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Betahistine dihydrochloride |
Betahistine is a diamine oxidase inhibitor. It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the conical artery system. It significantly increases the blood flow of the heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure. In addition, it can increase the blood flow of the cochlea and vestibule, thereby eliminating inner ear vertigo, tinnitus and ear closure. It can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema. It can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and it has the effect of inhibiting blood coagulation and ADP-induced platelet aggregation, it can prolong the time of thrombosis in vitro in rats, and it also has a slight diuretic effect.
More
Betahistine is a diamine oxidase inhibitor. It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the conical artery system. It significantly increases the blood flow of the heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure. In addition, it can increase the blood flow of the cochlea and vestibule, thereby eliminating inner ear vertigo, tinnitus and ear closure. It can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema. It can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and it has the effect of inhibiting blood coagulation and ADP-induced platelet aggregation, it can prolong the time of thrombosis in vitro in rats, and it also has a slight diuretic effect. |
5579-84-0 | 21 |